div > div.group > p:first-child"> Biogen — The drugmaker announced a new $5 billion share repurchase program, in addition to the $1.7 billion remaining under a prior authorization. That follows the stock's plunge last week, following the decision to end a late stage study of an Alzheimer's treatment that did not produce the desired results.
Fiat Chrysler — Fiat Chrysler rebuffed a merger approach from Peugeot parent PSA Group earlier this year, according to The Wall Street Journal. The FT reports, however, that the company's chairman, John Elkann, is making a renewed push to team up with another automaker. Winnebago — The recreational vehicle maker earned an adjusted 60 cents per share for its fiscal second quarter, 2 cents a share above estimates. Revenue was short of Wall Street forecasts, however, and Winnebago said market conditions have been challenging over the past six months. The company said it is optimistic that conditions are improving.
Allergan — Allergan said it would split its chairman and chief executive roles, but not until its next leadership change. Activist investor Appaloosa has been pushing for an immediate split of the two roles.
I'm guessing there's a problem with due diligence. ToxicAsset DeutscheBank Deutsche Bank and German rival commerzbank have hit a snag in their merger talks, according to wsjournal, with the fate of Deutsche Bank's U.S. operations among the contentious issues.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
La source: CNBC - 🏆 12. / 72 Lire la suite »
La source: CNBC - 🏆 12. / 72 Lire la suite »
La source: CNBC - 🏆 12. / 72 Lire la suite »
La source: CNBC - 🏆 12. / 72 Lire la suite »
La source: CNBC - 🏆 12. / 72 Lire la suite »
La source: MarketWatch - 🏆 3. / 97 Lire la suite »
La source: MarketWatch - 🏆 3. / 97 Lire la suite »